Search
Codexis Inc
CDXSAdd to Watchlist
2.470USD
+0.080+3.35%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
222.99MMarket Cap
LossP/E TTM
More Details of Codexis Inc Company
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Codexis Inc Info
Ticker SymbolCDXS
Company nameCodexis Inc
IPO dateApr 22, 2010
CEOMoore (Alison)
Number of employees188
Security typeOrdinary Share
Fiscal year-endApr 22
Address200 Penobscot Dr
CityREDWOOD CITY
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94063
Phone16504218100
Websitehttps://www.codexis.com/
Ticker SymbolCDXS
IPO dateApr 22, 2010
CEOMoore (Alison)
Company Executives of Codexis Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+9.69%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.44%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
137.05K
+3.65%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
--
Ms. Cynthia Collins
Ms. Cynthia Collins
Independent Director
Independent Director
112.16K
--
Mr. Christos Richards
Mr. Christos Richards
Independent Director
Independent Director
85.13K
--
Dr. Raymond De Vre, Ph.D.
Dr. Raymond De Vre, Ph.D.
Independent Director
Independent Director
84.81K
-3.07%
Ms. Georgia L. Erbez
Ms. Georgia L. Erbez
Chief Financial Officer
Chief Financial Officer
66.81K
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+9.69%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.44%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
137.05K
+3.65%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
--
FAQs
Who are the top five shareholders of Codexis Inc?
The top five shareholders of Codexis Inc are: Dr. Alison Moore, Ph.D.
How many institutions hold shares of Codexis Inc (CDXS)?
As of 2026Q1, 273 institutions hold shares of Codexis Inc, with a combined market value of approximately 66.34M, accounting for 73.00% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -13883230.00.